HCAR1
Hydroxycarboxylic acid receptor 1
Also known as: FKSG80, GPR104, GPR81, HCA1, HCAR1_HUMAN, LACR1, TA-GPCR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BXC0
- Gene
- HCAR1
- Ensembl
- ENSG00000196917
- Chromosome
- 12
- Canonical length
- 346 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
G protein-coupled receptors (GPCRs, or GPRs), such as GPR81, contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins.[supplied by OMIM, Feb 2005]
Canonical amino-acid sequenceUniProt
346 residues, UniProt reviewed canonical sequence.
>Q9BXC0|HCAR1
1 MYNGSCCRIE GDTISQVMPP LLIVAFVLGA LGNGVALCGF CFHMKTWKPS TVYLFNLAVA
61 DFLLMICLPF RTDYYLRRRH WAFGDIPCRV GLFTLAMNRA GSIVFLTVVA ADRYFKVVHP
121 HHAVNTISTR VAAGIVCTLW ALVILGTVYL LLENHLCVQE TAVSCESFIM ESANGWHDIM
181 FQLEFFMPLG IILFCSFKIV WSLRRRQQLA RQARMKKATR FIMVVAIVFI TCYLPSVSAR
241 LYFLWTVPSS ACDPSVHGAL HITLSFTYMN SMLDPLVYYF SSPSFPKFYN KLKICSLKPK
301 QPGHSKTQRP EEMPISNLGR RSCISVANSF QSQSDGQWDP HIVEWHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HCAR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 38 nTPM
- breast: 11 nTPM
- adipose tissue: 5.1 nTPM
- seminal vesicle: 4.7 nTPM
- salivary gland: 4.6 nTPM
- spleen: 2.1 nTPM
Single-cell type
- breast hormone-responsive cells: 16 nCPM
- early spermatids: 14 nCPM
- renal collecting duct intercalated cells: 12 nCPM
- salivary acinar cells: 9.2 nCPM
- transitional alveolar cells: 9.1 nCPM
- adipocytes: 8.5 nCPM
Immune cell
- basophil: 1.7 nTPM
- neutrophil: 1.1 nTPM
- NK-cell: 0.4 nTPM
- naive B-cell: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
- classical monocyte: 0.2 nTPM
Brain region
- cerebellum: 5.5 nTPM
- white matter: 4.9 nTPM
- cerebral cortex: 4.2 nTPM
- choroid plexus: 4.1 nTPM
- medulla oblongata: 3.9 nTPM
- amygdala: 3.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.17
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- G protein-coupled receptor signaling pathway
- negative regulation of lipid catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HCAR1 as an antibody target. Whether an autoantibody or antibody against HCAR1 could matter depends on whether native HCAR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HCAR1 is annotated at the cell surface, where native HCAR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HCAR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...